REVERSAL OR NITROGLYCERIN TOLERANCE BY THE CGMP PHOSPHODIESTERASE INHIBITOR ZAPRINAST

被引：24

作者：

SILVER, PJ

PAGANI, ED

DEGARAVILLA, L

VANALLER, GS

VOLBERG, ML

PRATT, PF

BUCHHOLZ, RA

机构：

[1] Department of Cardiovascular Pharmacology, Sterling Research Group, Rensselaer

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1991年 / 199卷 / 01期

关键词：

D O I：

10.1016/0014-2999(91)90652-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

收藏

页码：141 / 142

页数：2

相关论文

共 4 条

[1] NITRATE TOLERANCE FROM A BIOCHEMICAL POINT-OF-VIEW
AXELSSON, KL
AHLNER, J
[J]. DRUGS, 1987, 33 : 63 - 68
[2] SODIUM-NITROPRUSSIDE POTENTIATES THE DEPRESSOR RESPONSE TO THE PHOSPHODIESTERASE INHIBITOR ZAPRINAST IN RATS
DUNDORE, RL
PRATT, PF
HALLENBECK, WD
WASSEY, ML
SILVER, PJ
BUCHHOLZ, RA
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (01) : 91 - 97
[3] HARRIS AL, 1989, J PHARMACOL EXP THER, V249, P394
[4] S-NITROSOTHIOLS AS VASODILATORS - IMPLICATIONS REGARDING TOLERANCE TO NITRIC OXIDE-CONTAINING VASODILATORS
HENRY, PJ
DRUMMER, OH
HOROWITZ, JD
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (03) : 757 - 766